Product Origin Matters When Selling To U.S. Govt., Settlement Shows
This article was originally published in PharmAsia News
Executive Summary
The orthopedic firm Smith & Nephew recently settled what may be the first suit targeting a medical device company for violations of the U.S. Trade Agreements Act, which requires products sold to the U.S. government to be made in the U.S. or in countries that have signed a trade agreement with the U.S.